Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case

Johnson & Johnson (JNJ) was ordered on Thursday by a jury in Missouri to pay $4.69 billion in damages to 22 women who claimed the company's baby powder contained asbestos that caused their ovarian cancer.

The jury award in the case included $550 million in compensatory damages and $4.14 billion in punitive damages, according to a statement from the attorneys representing the plaintiffs.

Johnson & Johnson shares fell $3.01, or 2.36%, in after-hours trading.

The company faces more than 9,000 cases over body powders containing talc, according to its latest quarterly filing with the SEC.

In a statement, the company said it would appeal the verdict, "which was the product of a fundamentally unfair process that allowed plaintiffs to present a group of 22 women, most of whom had no connection to Missouri, in a single case all alleging that they developed ovarian cancer."

More from Investing

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

How to Be a Tactical Investor in the Current Market

How to Be a Tactical Investor in the Current Market

Canopy Growth CEO: Here's What the Future of Cannabis Looks Like for Investors

Canopy Growth CEO: Here's What the Future of Cannabis Looks Like for Investors

A Guide to Investing in the Fast-Emerging Cannabis Industry

A Guide to Investing in the Fast-Emerging Cannabis Industry

Canopy's CEO and Constellation Brands COO Discuss the Many Uses of Cannabis

Canopy's CEO and Constellation Brands COO Discuss the Many Uses of Cannabis